Risk factors for postoperative respiratory mortality and morbidity in patients undergoing coronary artery bypass grafting

Anesthesiology and Pain Medicine

Volumn 2, Issue 2, 2012, Pages 60-65

  Rajaei, Samira ^a   Dabbagh, Ali ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Coronary Artery Bypass; Morbidity; Mortality; Postoperative Period; Risk Factors

Indexed keywords

EID: 84890691356     PISSN: 22287523     EISSN: 22287531     Source Type: Journal    
DOI: 10.5812/aapm.5228     Document Type: Review

References (60)

1. Reddy SL, Grayson AD, Griffiths EM, Pullan DM, Rashid A. Logistic risk model for prolonged ventilation after adult cardiac surgery. Ann Thorac Surg. 2007;84(2):528-36.
2. Faritous ZS, Aghdaie N, Yazdanian F, Azarfarin R, Dabbagh A. Perioperative risk factors for prolonged mechanical ventilation and tracheostomy in women undergoing coronary artery bypass graft with cardiopulmonary bypass. Saudi J Anaesth. 2011;5(2):167-9.
3. Antunes PE, de Oliveira JF, Antunes MJ. Risk-prediction for postoperative major morbidity in coronary surgery. Eur J Cardiothorac Surg. 2009;35(5):760-6; discussion 6-7.
4. Hannan EL, Samadashvili Z, Lahey SJ, Culliford AT, Higgins RS, Jordan D, et al. Predictors of postoperative hematocrit and association of hematocrit with adverse outcomes for coronary artery bypass graft surgery patients with cardiopulmonary bypass. J Card Surg. 2010;25(6):638-46.
5. Tan PJ, Xu M, Sessler DI, Bashour CA. Operation timing does not affect outcome after coronary artery bypass graft surgery. Anesthesiology. 2009;111(4):785-9.
6. Szeles TF, Yoshinaga EM, Alenca W, Brudniewski M, Ferreira FS, Auler JO, et al. Hypoxemia after myocardial revascularization: analysis of risk factors. Rev Bras Anestesiol. 2008;58(2):124-36.
7. Cywinski JB, Xu M, Sessler DI, Mason D, Koch CG. Predictors of prolonged postoperative endotracheal intubation in patients undergoing thoracotomy for lung resection. J Cardiothorac Vasc Anesth. 2009;23(6):766-9.
8. Ben-Abraham R, Efrati O, Mishali D, Yulia F, Vardi A, Barzilay Z, et al. Predictors for mortality after prolonged mechanical ventilation after cardiac surgery in children. J Crit Care. 2002;17(4):235-9.
9. Kollef MH, Wragge T, Pasque C. Determinants of mortality and multiorgan dysfunction in cardiac surgery patients requiring prolonged mechanical ventilation. Chest. 1995;107(5):1395-401.
10. Ferasatkish R, Dabbagh A, Alavi M, Mollasadeghi G, Hydarpur E, Moghadam AA, et al. Effect of magnesium sulfate on extubation time and acute pain in coronary artery bypass surgery. Acta Anaesthesiol Scand. 2008;52(10):1348-52.
11. Branca P, McGaw P, Light R. Factors associated with prolonged mechanical ventilation following coronary artery bypass surgery. Chest. 2001;119(2):537-46.
12. Toraman F, Senay S, Gullu U, Karabulut H, Alhan C. Readmission to the intensive care unit after fast-track cardiac surgery: an analysis of risk factors and outcome according to the type of operation. Heart Surg Forum. 2010;13(4):E212-7.
13. Azarasa M, Azarfarin R, Changizi A, Alizadehasl A. Substance use among Iranian cardiac surgery patients and its effects on shortterm outcome. Anesth Analg. 2009;109(5):1553-9.
14. Dabbagh A, Rajaei S, Shamsolahrar MH. The effect of intravenous magnesium sulfate on acute postoperative bleeding in elective coronary artery bypass surgery. J Perianesth Nurs. 2010;25(5):290-5.
15. Mangano DT, Tudor IC, Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med. 2006;354(4):353-65.
16. Mangano DT, Miao Y, Vuylsteke A, Tudor IC, Juneja R, Filipescu D, et al. Investigators of The Multicenter Study of Perioperative Ischemia Research Group; Ischemia Research and Education Foundation. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA. 2007;297(5):471-9.
17. Sato M, Suenaga E, Koga S, Matsuyama S, Kawasaki H, Maki F. Early tracheal extubation after on-pump coronary artery bypass grafting. Ann Thorac Cardiovasc Surg. 2009;15(4):239-42.
18. Takagi H, Manabe H, Kawai N, Goto SN, Umemoto T. Aprotinin increases mortality as compared with tranexamic acid in cardiac surgery: a meta-analysis of randomized head-to-head trials. Interact Cardiovasc Thorac Surg. 2009;9(1):98-101.
19. Augoustides JG. Perioperative safety of aprotinin in coronary artery bypass graft surgery: is there life after BART? Drug Saf. 2008;31(7):557-60.
20. Henry D, Carless P, Fergusson D, Laupacis A. The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis. CMAJ. 2009;180(2):183-93.
21. Ide M, Bolliger D, Taketomi T, Tanaka KA. Lessons from the aprotinin saga: current perspective on antifibrinolytic therapy in cardiac surgery. J Anesth. 2010;24(1):96-106.
22. Hill GE, Alonso A, Spurzem JR, Stammers AH, Robbins RA. Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humans. J Thorac Cardiovasc Surg. 1995;110(6):1658-62.
23. Ovrum E, Tangen G, Tollofsrud S, Ringdal MA, Oystese R, Istad R. Low postoperative dose of aprotinin reduces bleeding and is safe in patients receiving clopidogrel before coronary artery bypass surgery. A prospective randomized study. Interact Cardiovasc Thorac Surg. 2010;10(4):545-8.
24. El-Chami MF, Kilgo P, Thourani V, Lattouf OM, Delurgio DB, Guyton RA, et al. New-onset atrial fibrillation predicts long-term mortality after coronary artery bypass graft. J Am Coll Cardiol. 2010;55(13):1370-6.
25. Basiladze L, Prangishvili A, Chapidze G, Pirvelashvili E, Bakhutashvili Z. Coronary artery bypass grafting in patients with low ejection fraction. Georgian Med News. 2009(176):17-21.
26. Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg. 2002;21(2):232-44.
27. Kunes P, Mandak J, Harrer J, Kolackova M, Andrys C, Holicka M, et al. Up-regulation of the Apo/Fas (CD95) complex on neutrophils harvested during cardiac surgery: distinct findings in patients operated on with or without the use of cardiopulmonary bypass. Perfusion. 2010;25(1):41-6.
28. Warren OJ, Smith AJ, Alexiou C, Rogers PL, Jawad N, Vincent C, et al. The inflammatory response to cardiopulmonary bypass: part 1--mechanisms of pathogenesis. J Cardiothorac Vasc Anesth. 2009;23(2):223-31.
29. Warren OJ, Watret AL, de Wit KL, Alexiou C, Vincent C, Darzi AW, et al. The inflammatory response to cardiopulmonary bypass: part 2--anti-inflammatory therapeutic strategies. J Cardiothorac Vasc Anesth. 2009;23(3):384-93.
30. Mistiaen W, Van Cauwelaert P, Muylaert P, De Worm E. A thousand pericardial valves in aortic position: risk factors for postoperative acute renal function impairment in elderly. J Cardiovasc Surg (Torino). 2009;50(2):233-7.
31. Chikwe J, Croft LB, Goldstone AB, Castillo JG, Rahmanian PB, Adams DH, et al. Comparison of the results of aortic valve replacement with or without concomitant coronary artery bypass grafting in patients with left ventricular ejection fraction < or =30% versus patients with ejection fraction >30%. Am J Cardiol. 2009;104(12):1717-21.
32. Ahmed WA, Tully PJ, Baker RA, Knight JL. Survival after isolated coronary artery bypass grafting in patients with severe left ventricular dysfunction. Ann Thorac Surg. 2009;87(4):1106-12.
33. El Diasty M, Gonzalez JA, Perez J, Cid F, Mosquera V, Cuenca J, et al. Early results of off-pump coronary artery bypass graft surgery using bilateral internal thoracic artery grafts in octogenarian patients during ten years. Interact Cardiovasc Thorac Surg. 2009;8(1):104-7.
34. Cooper WA, Thourani VH, Guyton RA, Kilgo P, Lattouf OM, Chen EP, et al. Racial disparity persists after on-pump and offpump coronary artery bypass grafting. Circulation. 2009;120(11 Suppl):S59-64.
35. Cislaghi F, Condemi AM, Corona A. Predictors of prolonged mechanical ventilation in a cohort of 5123 cardiac surgical patients. Eur J Anaesthesiol. 2009;26(5):396-403.
36. Cwynar R, Albert NM, Butler R, Hall C. Factors associated with long hospital length of stay in patients receiving warfarin after cardiac surgery. J Cardiovasc Nurs. 2009;24(6):465-74.
37. Luciani N, Nasso G, Gaudino M, Abbate A, Glieca F, Alessandrini F, et al. Coronary artery bypass grafting in type II diabetic patients: a comparison between insulin-dependent and non-insulin-dependent patients at short-and mid-term follow-up. Ann Thorac Surg. 2003;76(4):1149-54.
38. Kor DJ, Warner DO, Alsara A, Fernandez-Perez ER, Malinchoc M, Kashyap R, et al. Derivation and diagnostic accuracy of the surgical lung injury prediction model. Anesthesiology. 2011;115(1):117-28.
39. Fukui T, Shimokawa T, Manabe S, Morita S, Takanashi S. Prior inferior myocardial infarction has worse early outcomes in patients undergoing coronary artery bypass grafting than prior anterior myocardial infarction. Ann Thorac Surg. 2009;87(2):475-80.
40. Litmathe J, Kurt M, Feindt P, Gams E, Boeken U. Predictors and outcome of ICU readmission after cardiac surgery. Thorac Cardiovasc Surg. 2009;57(7):391-4.
41. O'Rourke DJ, Quinton HB, Piper W, Hernandez F, Morton J, Hettleman B, et al. Survival in patients with peripheral vascular disease after percutaneous coronary intervention and coronary artery bypass graft surgery. Ann Thorac Surg. 2004;78(2):466-70; discussion 70.
42. Park YJ, Yoon JW, Kim KI, Lee YJ, Kim KW, Choi SH, et al. Subclinical hypothyroidism might increase the risk of transient atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg. 2009;87(6):1846-52.
43. Sirvinskas E, Andrejaitiene J, Raliene L, Nasvytis L, Karbonskiene A, Pilvinis V, et al. Cardiopulmonary bypass management and acute renal failure: risk factors and prognosis. Perfusion. 2008;23(6):323-7.
44. Weiss ES, Chang DD, Joyce DL, Nwakanma LU, Yuh DD. Optimal timing of coronary artery bypass after acute myocardial infarction: a review of California discharge data. J Thorac Cardiovasc Surg. 2008;135(3):503-11, 11 e1-3.
45. Papadimos TJ, Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ, et al. Early efficacy of CABG care delivery in a low procedure-volume community hospital: operative and midterm results. BMC Surg. 2005;5:10.
46. Elahi M, Matata B, Yii M. Ethnicity and adverse operative outcomes among Australian patients undergoing first-time isolated coronary artery bypass graft surgery. Int Surg. 2008;93(6):358-65.
47. Sawatzky JA, Naimark BJ. The coronary artery bypass graft surgery trajectory: Gender differences revisited. Eur J Cardiovasc Nurs. 2009;8(4):302-8.
48. Leeper B. Impact of obesity on care of postoperative coronary bypass patients. Crit Care Nurs Clin North Am. 2009;21(3):369-75, vi.
49. Pan W, Hindler K, Lee VV, Vaughn WK, Collard CD. Obesity in diabetic patients undergoing coronary artery bypass graft surgery is associated with increased postoperative morbidity. Anesthesiology. 2006;104(3):441-7.
50. Tolpin DA, Collard CD, Lee VV, Elayda MA, Pan W. Obesity is associated with increased morbidity after coronary artery bypass graft surgery in patients with renal insufficiency. J Thorac Cardiovasc Surg. 2009;138(4):873-9.
51. Virani SS, Nambi V, Lee VV, Elayda MA, Pan W, Petersen LA, et al. Obesity: an independent predictor of in-hospital postoperative renal insufficiency among patients undergoing cardiac surgery? Tex Heart Inst J. 2009;36(6):540-5.
52. Kulik A, Ruel M. Statins and coronary artery bypass graft surgery: preoperative and postoperative efficacy and safety. Expert Opin Drug Saf. 2009;8(5):559-71.
53. Kinlin LM, Kirchner C, Zhang H, Daley J, Fisman DN. Derivation and validation of a clinical prediction rule for nosocomial pneumonia after coronary artery bypass graft surgery. Clin Infect Dis. 2010;50(4):493-501.
54. Rady MY, Ryan T. Perioperative predictors of extubation failure and the effect on clinical outcome after cardiac surgery. Crit Care Med. 1999;27(2):340-7.
55. Canver CC, Chanda J. Intraoperative and postoperative risk factors for respiratory failure after coronary bypass. Ann Thorac Surg. 2003;75(3):853-7; discussion 7-8.
56. Spivack SD, Shinozaki T, Albertini JJ, Deane R. Preoperative prediction of postoperative respiratory outcome. Coronary artery bypass grafting. Chest. 1996;109(5):1222-30.
57. Nashef SA, Roques F, Hammill BG, Peterson ED, Michel P, Grover FL, et al. Validation of European System for Cardiac Operative Risk Evaluation (EuroSCORE) in North American cardiac surgery. Eur J Cardiothorac Surg. 2002;22(1):101-5.
58. Roques F, Michel P, Goldstone AR, Nashef SA. The logistic EuroSCORE. Eur Heart J. 2003;24(9):881-2.
59. Choong CK, Sergeant P, Nashef SA, Smith JA, Bridgewater B. The EuroSCORE risk stratification system in the current era: how accurate is it and what should be done if it is inaccurate? Eur J Cardiothorac Surg. 2009;35(1):59-61.
60. Nashef SA. Editorial comment: What to do with EuroSCORE in 2009? Eur J Cardiothorac Surg. 2009;36(5):805-6.